 retrospective analysis therapy acute graft-versus-host disease secondary treatment results secondary therapy patients acute graft-versus-host disease GVHD durable satisfactory response primary treatment beginning secondary treatment patients dysfunction dysfunction Secondary treatment glucocorticoids cyclosporine antithymocyte globulin monoclonal antibody combination Parameters GVHD severity responses values initiation tertiary treatment patients treatment values day secondary treatment last recorded values death Minimal criteria improvement deterioration organ attempt liver outcome complication venocclusive disease infectious enteritis present Improvement resolution GVHD respective organ patients skin disease patients evaluable liver disease patients evaluable gut disease Overall complete partial responses patients complete response rate secondary therapy GVHD taper phase primary glucocorticoid treatment dose glucocorticoids Multivariate analyses patient disease treatment factors likelihood complete response overall improvement similar analysis covariates time treatment failure initiation tertiary therapy death due malignancy Severe dysfunction skin liver gut beginning treatment decreased likelihood complete response treatment failure rate times treatment failure proportions patients various response categories similar primary secondary treatment potential efficacy new immunosuppressive agents treatment acute GVHD patients initial therapy